Tezepelumab as an Add-on Maintenance Treatment ...

By HEOR Staff Writer

April 25, 2023

Tezepelumab as an add-on maintenance treatment is recommended as an option for severe asthma in people 12 years and over, when treatment with high-dose inhaled corticosteroids plus another maintenance treatment has failed. It is recommended onl...
Clinical evidence shows that AposHealth (an FDA-cleared medical device) impro...
Chronic Heart Failure: PBAC Recommends Empagliflozin
Genedrive MT-RNR1 ID Kit to detect genetic variation and protect hearing in b...
Abu Dhabi Recognises Abu Dhabi Stem Cells Center (ADSCC) as a Centre of Excel...
Did CVDs recover post COVID-19 ?
The evidence for Cannabidiol is building
Mobocertinib added in NICE guidelines
HIQA on Gene Expression Profiling Tests for Breast Cancer
Upadacitinib: A Convenient and Effective Alternative Treatment for Spondyloar...
SAHPRA Approves Pfizer’s Paxlovid COVID-19 Treatment